Anxiety and depression often remain unrecognized or inadequately treated in patients with Parkinson disease (PD). Cognitive–behavioral therapy (CBT) is effective, but limited evidence supports its use for anxiety and depression in patients with PD. Sixteen patients with PD having significant anxiety and/or depressive symptoms were assigned to CBT or enhanced usual care. Assessments occurred at baseline, posttreatment, and 1-month follow-up. The CBT intervention included tools for anxiety, depression, and healthy living with PD symptoms. Individual sessions were delivered by telephone or in person, based on patient preference. Treatment was feasible with participants choosing 67% of sessions by telephone and 80% completed treatment. The between-group effect sizes for change scores from baseline to posttreatment and baseline to 1-month follow-up were large (posttreatment: d = 1.49 for depression and 1.44 for anxiety; 1-month follow-up: d = .73 for depression and 1.24 for anxiety), although only the posttreatment effect size for depression was significant. This pilot CBT program is feasible for treatment of anxiety and depression in patients with PD.
ReijndersJSEhrtUWeberWEAarslandDLeentjensAF. A systematic review of prevalence studies of depression in Parkinson’s disease. Mov Disord. 2008;23(2):183–189.
2.
PontoneGMWilliamsJRAndersonKE. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord. 2009;24(9):1333–1338.
3.
WitjasTKaphanEAzulayJP. Nonmotor fluctuations in Parkinson’s Disease. Neurology. 2002;59(3):408.
4.
ReutherMSpottkeEAKlotscheJ. Assessing health-related quality of life in patients with Parkinson’s disease in a prospective longitudinal study. Parkinsonism Relat Disord. 2007;13(2):108–114.
5.
Carod-ArtalFJZiomkowskiSMouraoMHMartinez-MartinP. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson’s disease. Parkinsonism Relat Disord. 2008;14(2):102–108.
6.
RichardIHMcDermottMPKurlanR. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology. 2012;78(16):1229–1236.
7.
PaternitiSDufouilCAlperovitchA. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol. 2002;22(3):285–293.
8.
CooperLMeulenersLBDukeJJanceyJHildebrandJ. Psychotropic medications and crash risk in older drivers: a review of the literature. Asia Pac J Public Health. 2011;23(4):443–457.
9.
OehlbergKBargFKBrownGKTaraborelliDSternMBWeintraubD. Attitudes regarding the etiology and treatment of depression in Parkinson’s disease: a qualitative study. J Geriatr Psychiatry Neurol. 2008;21(2):123–132.
10.
BarlowDH. Clinical Handbook of Psychological Disorders: A Step-by-Step Treatment Manual. 5th ed. New York, NY: Guilford Press, 2014.
11.
DobkinRDMenzaMAllenLA. Cognitive-behavioral therapy for depression in Parkinson’s disease: a randomized, controlled trial. Am J Psychiatry. 2011;168(10):1066–1074.
12.
OkaiDAskey-JonesSSamuelM. Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology. 2013;80(9):792–799.
13.
DobkinRDMenzaMAllenLA. Telephone based cognitive behavioral therapy for depression in Parkinson disease. J Geriatr Psychiatry Neurol. 2011;24(4):206–214.
14.
MohrDHoJDuffecyJ. Effect of telephone-administered vs. face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients. JAMA. 2012;307(21):2278–2285.
15.
BrenesGAMcCallWVWilliamsonJDStanleyMA. Feasibility and acceptability of bibliotherapy and telephone sessions for the treatment of late-life anxiety disorders. Clin Gerontol. 2010;33(1):62.
16.
StanleyMAWilsonNLNovyDM. Cognitive behavior therapy for generalized anxiety disorder among older adults in primary care: a randomized clinical trial. JAMA. 2009;301(14):1460–1467.
17.
StanleyMAWilsonNLAmspokerAB. Lay providers can deliver effective cognitive behavior therapy for older adults with generalized anxiety disorder: a randomized trial. Depress Anxiety. 2014;31(5):391–401. 10.1002/da.22239.
18.
VeazeyCCookKFStanleyMLaiECKunikME. Telephone-administered cognitive behavioral therapy: a case study of anxiety and depression in Parkinson’s disease. J Clin Psychol Med Settings. 2009;16(3):243–253.
19.
TroeungLEganSJGassonN. A waitlist-controlled trial of group cognitive behavioural therapy for depression and anxiety in Parkinson’s disease. BMC Psychiatry. 2014;14(1):19.
20.
ZigmondASSnaithRP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–370.
21.
SheikhJIYesavageJA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5(1/2):165–173.
22.
LuisCAKeeganAPMullanM. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US. Int J Geriatr Psychiatry. 2009;24(2):197–201.
23.
FirstMBSpitzerRLGibbonMWilliamsJB. Structured Clinical Interview for DSM-IV® Axis I Disorders (SCID-I), Clinician Version, Administration Booklet. Arlington, VA: American Psychiatric Publishing; 2012.
24.
AarslandDBronnickKWilliams-GrayC. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology. 2010;75(12):1062–1069.
25.
PaukertALCalleoJKraus-SchumanC. Peaceful Mind: an open trial of cognitive-behavioral therapy for anxiety in persons with dementia. Int Psychogeriatr2010;22(6):1012–1022.
26.
WilliamsJB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45(8):742–747.
27.
WilliamsJRHirschESAndersonK. A comparison of nine scales to detect depression in Parkinson disease. Neurology. 2012;78(13):998–1006.
28.
ShearMKVanderBJRucciP. Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety. 2001;13(4):166–178.
29.
LeetjensAFGDujardinKMarshLRichardIHStarksteinSEMartinez-MartinP. Anxiety rating scales in Parkinson’s disease: a validation of the Hamilton Anxiety Rating Scale, Beck Anxiety Inventory, and the Hospital Anxiety and Depression Scale. Mov Disord. 2011;26(3):407–415.
30.
RosemanASCullyJAKunikME. Treatment response for late-life generalized anxiety disorder: Moving beyond symptom-based measures. J Nerv Ment Disord. 2011;199(10):811–814.
